Cargando…

Apixaban for Secondary Stroke Prevention: Coexistant Cerebral Atherosclerosis May Increase Recurrent Strokes

BACKGROUND AND PURPOSE: Oral anticoagulants are needed in stroke patients with atrial fibrillation (AF) for the prevention of recurrent stroke. However, the risk of major events or bleeding may be greater in stroke patients than in those without, because the presence of cerebral atherosclerosis or s...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kim, Jong S., Koo, Jaseong, Shin, Dong-Ick, Kim, Byung-Su, Kim, Jei, Kim, Eung-Gyu, Hong, Keun-Sik, Yi, Hyeju
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Korean Stroke Society 2022
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8829474/ https://www.ncbi.nlm.nih.gov/pubmed/35135065 http://dx.doi.org/10.5853/jos.2021.02355

Ejemplares similares

New Oral Anticoagulants May Be Particularly Useful for Asian Stroke Patients
por: Bang, Oh Young, et al.
Publicado: (2014)

Low- versus Standard-Dose Intravenous Alteplase in the Context of Bridging Therapy for Acute Ischemic Stroke: A Korean ENCHANTED Study
por: Kim, Jong S., et al.
Publicado: (2018)

Intake of antioxidants and B vitamins is inversely associated with ischemic stroke and cerebral atherosclerosis
por: Choe, Hansaem, et al.
Publicado: (2016)

Relationship of Inter‐Individual Blood Pressure Variability and the Risk for Recurrent Stroke
por: Kim, Bum Joon, et al.
Publicado: (2018)

Chronic Lung Parenchymal Disease May Be Causally Associated With Cryptogenic Stroke With Massive Right-to-Left Shunt
por: Kim, Jong-Su, et al.
Publicado: (2023)

Accidental Thrombolysis in a Stroke Patient Receiving Apixaban
por: Fluri, Felix, et al.
Publicado: (2015)

Increasing Frequency and Burden of Cerebral Artery Atherosclerosis in Korean Stroke Patients
por: Kim, Young Dae, et al.
Publicado: (2010)

Enhancing the Therapeutic Potential of CCL2-Overexpressing Mesenchymal Stem Cells in Acute Stroke
por: Lee, Sanghun, et al.
Publicado: (2020)

Wall Shear Stress Associated with Stroke Occurrence and Mechanisms in Middle Cerebral Artery Atherosclerosis
por: Woo, Ho Geol, et al.
Publicado: (2023)

Apixaban in patients at risk of stroke undergoing atrial fibrillation ablation
por: Kirchhof, Paulus, et al.
Publicado: (2018)

Blood viscosity associated with stroke mechanism and early neurological deterioration in middle cerebral artery atherosclerosis
por: Woo, Ho Geol, et al.
Publicado: (2023)

Burden of Ischemic Stroke in Korea: Analysis of Disability-Adjusted Life Years Lost
por: Hong, Keun-Sik, et al.
Publicado: (2011)

Cardiac Function and Outcome in Patients with Cardio-Embolic Stroke
por: Byun, Jung-Ick, et al.
Publicado: (2014)

Risk of recurrent stroke and antiplatelet choice in breakthrough stroke while on aspirin
por: Kim, Joon-Tae, et al.
Publicado: (2020)

Cost-Effectiveness of Apixaban Compared with Warfarin for Stroke Prevention in Atrial Fibrillation
por: Lee, Soyon, et al.
Publicado: (2012)

Cost-effectiveness of Apixaban for Stroke Prevention in Patients with Atrial Fibrillation in Algeria
por: Aoudia, Yazid, et al.
Publicado: (2017)

The leukoaraiosis is more prevalent in the large artery atherosclerosis stroke subtype among Korean patients with ischemic stroke
por: Lee, Seung-Jae, et al.
Publicado: (2008)

Cerebral small vessel disease or intracranial large vessel atherosclerosis may carry different risk for future strokes
por: Chen, Huimin, et al.
Publicado: (2020)

Heart Failure as a Risk Factor for Stroke
por: Kim, Woohyeun, et al.
Publicado: (2018)

ABCG2 Gene Polymorphisms May Affect the Bleeding Risk in Patients on Apixaban and Rivaroxaban
por: Kim, Hamin, et al.
Publicado: (2023)

Coexistent cerebral small vessel disease and multiple infarctions predict recurrent stroke
por: Tian, Yu, et al.
Publicado: (2022)

Association of Systolic Blood Pressure and Cerebral Collateral Flow in Acute Ischemic Stroke by Stroke Subtype
por: Sim, Jae Eun, et al.
Publicado: (2022)

Imaging-Based Management of Acute Ischemic Stroke Patients: Current Neuroradiological Perspectives
por: Na, Dong Gyu, et al.
Publicado: (2015)

Executive Summary of Stroke Statistics in Korea 2018: A Report from the Epidemiology Research Council of the Korean Stroke Society
por: Kim, Jun Yup, et al.
Publicado: (2019)

A case of apixaban-associated idiopathic interstitial pneumonia
por: Yun, Won-Sik, et al.
Publicado: (2022)

Stroke Statistics in Korea: Part II Stroke Awareness and Acute Stroke Care, A Report from the Korean Stroke Society and Clinical Research Center For Stroke
por: Hong, Keun-Sik, et al.
Publicado: (2013)

Economic Evaluation of Warfarin, Dabigatran, Rivaroxaban, and Apixaban for Stroke Prevention in Atrial Fibrillation
por: Wisløff, Torbjørn, et al.
Publicado: (2014)

Economic Evaluation of Apixaban for the Prevention of Stroke in Non-Valvular Atrial Fibrillation in the Netherlands
por: Stevanović, Jelena, et al.
Publicado: (2014)

Apixaban: An Update of the Evidence for Its Place in the Prevention of Stroke in Patients with Atrial Fibrillation
por: Seeger, Julia, et al.
Publicado: (2020)

Intracranial Atherosclerosis Coexisting With White Matter Hyperintensities May Predict Unfavorable Functional Outcome in Patients With Acute Cerebral Ischemia
por: Liu, Haiyan, et al.
Publicado: (2020)

Antithrombotic treatments in patients with acute ischemic stroke and non-valvular atrial fibrillation before introduction of non-vitamin K antagonist oral anticoagulants into practice in Korea
por: Bae, Hee-Joon, et al.
Publicado: (2018)

Association of Sex With Stroke and Bleeding Risk of Apixaban and Rivaroxaban in Elderly Atrial Fibrillation Patients Using Propensity Score Weights
por: Gulilat, Markus, et al.
Publicado: (2021)

Safety and Efficacy of Otaplimastat in Patients with Acute Ischemic Stroke Requiring tPA (SAFE‐TPA): A Multicenter, Randomized, Double‐Blind, Placebo‐Controlled Phase 2 Study
por: Kim, Jong S., et al.
Publicado: (2019)

Plasma Fibroblast Growth Factor 23 Concentration Is Associated with Intracranial Cerebral Atherosclerosis in Acute Ischemic Stroke Patients
por: Chang, Yoonkyung, et al.
Publicado: (2020)

Effect and Safety of Rosuvastatin in Acute Ischemic Stroke
por: Heo, Ji Hoe, et al.
Publicado: (2016)

Stroke Prevention in Atrial Fibrillation: Understanding the New Oral Anticoagulants Dabigatran, Rivaroxaban, and Apixaban
por: Ru San, Tan, et al.
Publicado: (2012)

An evidence-based review of apixaban and its potential in the prevention of stroke in patients with atrial fibrillation
por: Deedwania, Prakash, et al.
Publicado: (2012)

Cost-Effectiveness Analysis of Apixaban Versus Edoxaban in Patients with Atrial Fibrillation for Stroke Prevention
por: Oyagüez, Itziar, et al.
Publicado: (2019)

Cost-effectiveness of apixaban for stroke prevention in non-valvular atrial fibrillation in Saudi Arabia
por: Hersi, Ahmad S., et al.
Publicado: (2019)

Differential impact of serum total bilirubin level on cerebral atherosclerosis and cerebral small vessel disease
por: Kim, Jonguk, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_8nb1na77lvo60ckoitrn04lukk